Rash of Generic Price Hikes Pushes UK Health Dept Into Action
Executive Summary
Huge hikes in the prices of some generic medicines in the past year have forced the UK health authorities to offer many more “concessionary prices” to pharmacists to ensure continuity of supply and to seek alternative sources of some products. Legislation is due to take effect shortly that will give the government more powers to control generic prices.
You may also be interested in...
Court Ruling On Pfizer Price Hikes Could Delay Other Investigations, Warns UK Competition Authority
Ongoing Investigations into drug price increases could be at risk following a tribunal ruling in the UK phenytoin sodium case, according to the Competition and Markets Authority, which is considering an appeal against the judgment.
ABPI Welcomes Amended Legislation On Curbing Excessive Unbranded Drug Prices
Newly passed UK legislation gives the government powers to curb pricing of unbranded generics when market forces fail. The Association of the British Pharmaceutical Industry has welcomed amendments to draft legislation that have addressed its concerns over onerous requirements.
EU Review Proposals ‘Fail To Analyze’ Impact Of Reduced Exclusivity Periods
Plans for the overhaul of the EU’s medicines framework are missing key analysis on the effect of reductions in data and market protection on the pharmaceutical industry, despite an abundance of studies on how such incentives influence company decisions on whether to develop new products, say lawyers from Sidley.